Replies to post #89 on Ligand Pharma Inc Roche Contingent Value Rights (LGNDZ)

[vladster]

What's wrong with this stock?

Bleeding down now steady since above $3 in August. Seems like they struck a couple of nice little deals on Neurogen and Metabasis which should have added value to the company yet we see a 40% decline in market cap!